Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane
Consumption of Rocuronium Under Etomidate-based Versus Propofol-based Maintenance of General Anesthesia Under Different Concentration of Sevoflurane- BIS Guided Clinical Trial in a Closed Loop Infusion System
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI < 30
- elective Gynaecological/abdominal/urological surgery
- Operation time < 3hrs
- ASA I/II
- Intubated patients
Exclusion Criteria:
- Coronary artery disease, cardiac, lung, hepatic and renal insufficiency
- Severe uncontrolled HBP
- Obesity (BMI >30)
- Neuromuscular and metabolic diseases
- Receiving medication known to influence neuromuscular transmission
- Pregnancy
- Psychiatric disorders
- Allergy history to any of the drugs that will be used
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: SP1- sevoflurane MAC 0.5
In this group, patient of age 40-60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, Sevoflurane is started to achieve the desired MAC of 0.5.
Propofol infusion is started to keep BIS between 40-60.
|
0.5 MAC Sevoflurane
Propofol consumption
Consumption of Rocuronium
|
|
Experimental: SP2- Sevoflurane MAC 0.75
In this group, patient of age 40-60 years, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, Sevoflurane is started to achieve the desired MAC of 0.75.
Propofol infusion is started to keep BIS between 40-60.
|
Propofol consumption
Consumption of Rocuronium
0.75 MAC Sevoflurane
|
|
Experimental: SP3 -Sevoflurane MAC 1.0
In this group, patient of age 40-60 years, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, Sevoflurane is started to achieve the desired MAC of 1.0.
Propofol infusion is started to keep BIS between 40-60.
|
Propofol consumption
Consumption of Rocuronium
1.0 MAC Sevoflurane
|
|
Experimental: SP4- Sevoflurane MAC 0.5
In this group, patient above 60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, sevoflurane is started to achieve the desired MAC of 0.5.
Propofol infusion is started to keep BIS between 40-60.
|
0.5 MAC Sevoflurane
Propofol consumption
Consumption of Rocuronium
|
|
Experimental: SP5- Sevoflurane MAC 0.75
In this group, patient above 60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, Sevoflurane is started to achieve the desired MAC of 0.75.
Propofol infusion is started to keep BIS between 40-60.
|
Propofol consumption
Consumption of Rocuronium
0.75 MAC Sevoflurane
|
|
Experimental: SE1- Sevoflurane MAC 0.5
In this group, patient of age 40-60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, sevoflurane is started to achieve the desired MAC of 0.5.
Etomidate infusion is started to keep BIS between 40-60.
|
0.5 MAC Sevoflurane
Consumption of Rocuronium
Etomidate consumption
|
|
Experimental: SE2- Sevoflurane 0.75
In this group, patient of age 40-60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, sevoflurane is started to achieve the desired MAC of 0.5.
Etomidate infusion is started to keep BIS between 40-60.
|
Consumption of Rocuronium
0.75 MAC Sevoflurane
Etomidate consumption
|
|
Experimental: SE3- Sevoflurane MAC 1.0
In this group, patient of age 40-60 years of age, ASA I/II, undergoing elective abdominal or gynecological surgery are chosen.
Neuromuscular function prior to induction is assessed by acceleromyography by stimulation of ulnar nerve and noting the response of adductor pollicis.
After induction and intubation, Sevoflurane is started to achieve the desired MAC of 0.5.
Etomidate infusion is started to keep BIS between 40-60.
|
Consumption of Rocuronium
1.0 MAC Sevoflurane
Etomidate consumption
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
consumption of propofol
Time Frame: Intraoperative
|
Propofol, Etomidate, Rocuronium consumption under specific concentration of sevoflurane keeping BIS between 40-60
|
Intraoperative
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recovery Index
Time Frame: Intraoperative
|
T25%-T75%
|
Intraoperative
|
|
Onset time
Time Frame: Intraoperative
|
Time from starting infusion of Rocuronium at induction till T<10%
|
Intraoperative
|
|
Sevoflurane time
Time Frame: Intraoperative
|
Time from starting sevoflurane till end tidal concentration is reached
|
Intraoperative
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Guolin Wang, Professor, Head of department anesthesiology
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TianjinMUGH
- Narina Goulvaden (Other Identifier: Tianjin medical university)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.